Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma.

PLoS One · 2010 · PMC2841188 · PMID 20305783

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This effect was seen only at 10∶1 ratio of hMSCs to U87 glioma cells, however, the difference did not reach statistical significance ( Figure 1A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.